69 related articles for article (PubMed ID: 18438329)
1. Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective.
Backeljauw PF; Andrews M; Bang P; Dalle Molle L; Deal CL; Harvey J; Langham S; Petriczko E; Polak M; Storr HL; Dattani MT
Orphanet J Rare Dis; 2023 Oct; 18(1):312. PubMed ID: 37805563
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Natural Product-Derived Extracts for Longitudinal Bone Growth: An Overview of In Vivo Experiments.
Lim DW; Lee C
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068932
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
4. Statement 5: the first line of treatment for children with idiopathic short stature (ISS) and low serum insulin-like growth factor-I (IGF-I) should be IGF-I.
Backeljauw P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():853-6. PubMed ID: 18438329
[No Abstract] [Full Text] [Related]
5. Statement 3: a low serum IGF-I Level in idiopathic short stature patients indicates partial GH insensitivity.
Bang P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():841-6. PubMed ID: 18438327
[No Abstract] [Full Text] [Related]
6. Treatment perspectives in idiopathic short stature with a focus on IGF-I deficiency.
Rosenthal S; Cohen P; Clayton P; Backeljauw P; Bang P; Ten S
Pediatr Endocrinol Rev; 2007 May; 4 Suppl 2():252-71. PubMed ID: 17581497
[No Abstract] [Full Text] [Related]
7. Statement 1: a serum insulin-like growth factor I (IGF-I) level should be part of the evaluation of children with short stature.
Cohen P
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():834-6. PubMed ID: 18438325
[No Abstract] [Full Text] [Related]
8. Statement 6: patients who are unresponsive to GH therapy should be given a trial of IGF-I.
Hardin DS
Pediatr Endocrinol Rev; 2008 Apr; 5 Suppl 3():857-60. PubMed ID: 18438330
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
